Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

DOI Full Paper Access

206

Citations

24

References

2022

Year

Markus P. Schlaich, M Bellet, Michael A. Weber, Parisa Danaietash, George L. Bakris, John M. Flack, Roland F. Dreier, Mouna Sassi-Sayadi, Lloyd Haskell, Krzysztof Narkiewicz,

Molecular PharmacologyHypertensionResistant HypertensionCardiovascular DiseaseAntihypertensive TherapyVascular PharmacologyPharmacologyCardiovascular PharmacologyVascular BiologyPharmacotherapyMedicineBlood Pressure

References

	Year	Citations

Page 1

Page 1